首页> 外文期刊>Chemical Business >Aurobindo Pharma, Pfizer in pact
【24h】

Aurobindo Pharma, Pfizer in pact

机译:辉瑞制药公司Aurobindo Pharma

获取原文
获取原文并翻译 | 示例
       

摘要

AUROBINDO Pharma Ltd has entered into licensing and supply agreements with US pharma major, Pfizer Inc, for several solid dosage and sterile products. The agreements, the details of which were not disclosed, would give the Hyderabad-based company access to Pfizer's newly-formed established product business unit to exploit the sales potential for the post loss of exclusivity (LOE) products through its global commercial presence.
机译:AUROBINDO Pharma Ltd已与美国制药巨头辉瑞公司(Pfizer Inc)签订了许可和供应协议,涉及几种固体剂和无菌产品。该协议的细节尚未披露,将使这家总部位于海得拉巴的公司能够进入辉瑞公司新成立的产品业务部门,以通过其全球商业地位来挖掘排他后专有(LOE)产品的销售潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号